Follow
Michelle Teplensky
Michelle Teplensky
Assistant Professor at Boston University
Verified email at bu.edu - Homepage
Title
Cited by
Cited by
Year
Temperature treatment of highly porous zirconium-containing metal–organic frameworks extends drug delivery release
MH Teplensky, M Fantham, P Li, TC Wang, JP Mehta, LJ Young, ...
Journal of the American chemical society 139 (22), 7522-7532, 2017
3252017
Metal-organic frameworks as biosensors for luminescence-based detection and imaging
SE Miller, MH Teplensky, PZ Moghadam, D Fairen-Jimenez
Interface Focus 6 (4), 20160027, 2016
1792016
A highly porous metal-organic framework system to deliver payloads for gene knockdown
MH Teplensky, M Fantham, C Poudel, C Hockings, M Lu, A Guna, ...
Chem 5 (11), 2926-2941, 2019
89*2019
Multi-antigen spherical nucleic acid cancer vaccines
MH Teplensky, M Evangelopoulos, JW Dittmar, CM Forsyth, AJ Sinegra, ...
Nature biomedical engineering 7 (7), 911-927, 2023
522023
DNA dendrons as agents for intracellular delivery
ME Distler, MH Teplensky, KE Bujold, CD Kusmierz, M Evangelopoulos, ...
Journal of the American Chemical Society 143 (34), 13513-13518, 2021
392021
Spherical Nucleic Acid Vaccine Structure Markedly Influences Adaptive Immune Responses of Clinically Utilized Prostate Cancer Targets
MH Teplensky, JW Dittmar, L Qin, S Wang, M Evangelopoulos, B Zhang, ...
Advanced healthcare materials, e2101262, 2021
332021
Spherical nucleic acids as an infectious disease vaccine platform
MH Teplensky, ME Distler, CD Kusmierz, M Evangelopoulos, H Gula, ...
Proceedings of the National Academy of Sciences 119 (14), e2119093119, 2022
302022
Chemically tuning the antigen release kinetics from spherical nucleic acids maximizes immune stimulation
K Skakuj, MH Teplensky, S Wang, JW Dittmar, CA Mirkin
ACS central science 7 (11), 1838-1846, 2021
202021
Molecular DNA dendron vaccines
ME Distler, JP Cavaliere, MH Teplensky, M Evangelopoulos, CA Mirkin
Proceedings of the National Academy of Sciences 120 (5), e2215091120, 2023
122023
Tuning DNA Dissociation from Spherical Nucleic Acids for Enhanced Immunostimulation
JW Dittmar, MH Teplensky, M Evangelopoulos, L Qin, B Zhang, CA Mirkin
ACS nano 17 (18), 17996-18007, 2023
72023
Modular nucleic acid scaffolds for synthesizing monodisperse and sequence-encoded antibody oligomers
PH Winegar, CA Figg, MH Teplensky, N Ramani, CA Mirkin
Chem 8 (11), 3018-3030, 2022
72022
Controlling intracellular machinery via polymer pen lithography molecular patterning
M Lin, B Meckes, C Chen, MH Teplensky, CA Mirkin
ACS Central Science 8 (9), 1282-1289, 2022
52022
Amorphous metal-organic frameworks
C Orellana-Tavra, N Slater, D Fairen-Jimenez, M Teplensky, E Baxter, ...
US Patent 11,083,795, 2021
52021
Harnessing biomaterial architecture to drive anticancer innate immunity
MA Davis, E Cho, MH Teplensky
Journal of Materials Chemistry B 11 (46), 10982-11005, 2023
12023
Abstract A025: RNA-Based Therapeutics to target the p53 pathway in high-grade serous ovarian cancer: TAp63-Regulated Oncogenic LncRNAs (TROLLs) as novel therapeutic targets in …
A Lui, M Napoli, JR Baldwin, CL Carr, A Rivera, D Nguyen, WG Sawyer, ...
Molecular Cancer Therapeutics 23 (11_Supplement), A025-A025, 2024
2024
Abstract B011: RNA-based therapeutics to target the p53 pathway in cancer
M Napoli, AK Lu, AA Deshpande, JR Baldwin, CL Carr, MR Dunne, ...
Molecular Cancer Therapeutics 23 (11_Supplement), B011-B011, 2024
2024
Drug and Gene Delivery III: Emerging Technologies
D Samanta, A Brown, L Volpatti, M Teplensky
2024 AIChE Annual Meeting, 2024
2024
Drug and Gene Delivery II: Investigations towards Neuro & the Brain
R Chattaraj, M Teplensky, L Volpatti
2024 AIChE Annual Meeting, 2024
2024
Drug and Gene Delivery: Vaccines and Immunotherapy
M Teplensky, L Volpatti
2024 AIChE Annual Meeting, 2024
2024
Targeting multiple t cell types using spherical nucleic acid vaccine architecture
CA Mirkin, MH Teplensky, M Evangelopoulos, S Wang
US Patent App. 18/283,699, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20